Mark Michalski, M.D.

Mark Michalski, M.D., is Chief Information Officer and joined the Firm in 2024. As CIO, Mark leads the Deerfield Intelligence team and is responsible for overseeing the expansion and launch of new software and AI enabled products and services and supporting related capabilities for portfolio companies. Dr. Michalski concurrently serves as Chief Executive Officer at Ascertain, a technology company specializing in AI-driven automation solutions for healthcare enterprises. Before this, Dr. Michalski led strategic business development for Amazon’s healthcare and life sciences business units. He also served as Founding Executive Director of Mass General Brigham AI (formerly the Center for Clinical Data Science). Earlier in his career, Dr. Michalski served as President and Chief Medical Officer at Butterfly Network (NYSE: BFLY) and Chief Medical Officer at Hyperfine Research (NASDAQ: HYPR). Dr. Michalski holds a B.S. in Cybernetics from University of California, Los Angeles, a M.D. from Stanford University School of Medicine, and completed residency training at Yale New Haven Hospital. Dr. Michalski is certified by the American Board of Radiology and holds a medical license in New York State.